Clinical Trials in Seattle

Showing 961-980 of 8,049 trials

A Study of AZD0120 in Autoimmune Diseases

NCT07295847

This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arthritis (D2T RA).

Systemic SclerosisIdiopathic Inflammatory MyopathiesRheumatoid Arthritis

AstraZeneca27 participantsStarted Jan 2026

Tucson, Arizona, United States • Stanford, California, United States • Chicago, Illinois, United States +15 more locations

RECRUITINGPhase 3< 1 mile

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

89bio, Inc.1,350 participantsStarted Mar 2024

Birmingham, Alabama, United States • Chandler, Arizona, United States • Flagstaff, Arizona, United States +328 more locations

A Study of AZD0120 in Autoimmune Diseases

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Find Trials by Condition in Seattle

Siplizumab in T1DM

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

A Study of Navenibart in Participants With Hereditary Angioedema

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)